Autoimmune polyglandular syndrome, type II

American Family Physician

Volumn 75, Issue 5, 2007, Pages 667-670

  Majeroni, Barbara A ^a,b   Patel, Parag ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; LEUKOCYTE ANTIGEN; STEROID 21 MONOOXYGENASE; TETRACOSACTIDE;

ADRENAL CORTEX INSUFFICIENCY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE II; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENE LOCUS; HAPLOTYPE; HORMONAL THERAPY; HUMAN; HYDROCORTISONE BLOOD LEVEL; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; THYROID DISEASE;

ADRENAL INSUFFICIENCY; COSYNTROPIN; HORMONES; HUMANS; HYDROCORTISONE; POLYENDOCRINOPATHIES, AUTOIMMUNE;

EID: 33947115274     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction [Published correction appears in Endocr Rev 2002;23:579]. Endocr Rev 2002;23:327-64.
2. Falorni A, Laurenti S, Santeusanio F. Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 2002;31:369-89.
3. Lovas K, Husebye ES. High prevalence and increasing incidence of Addison's disease in western Norway. Clin Endocrinol (Oxf) 2002;56:787-91.
4. Laureti S, Vecchi L Santeusanio F, Falorni A. Is the prevalence of Addison's disease underestimated? J Clin Endocrinol Metab 1999;84:1762.
5. Muir A, Schatz DA, Maclaren NK. Autoimmune Addison's disease. Springer Semin Immunopathol 1993;14:275-84.
6. Betterle C, Volpato M, Greggio AN, Presotto F. Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pediatr Endocrinol Metab 1996;9(suppl 1):113-23.
7. Schatz DA, Winter WE. Autoimmune polyglandular syndrome. II: Clinical syndrome and treatment. Endocrinol Metab Clin North Am 2002;31:339-52.
8. Graves L III, Klein RM, Walling AD. Addisonian crisis precipitated by thyroxine therapy: a complication of type 2 autoimmune polyglandular syndrome. South Med J 2003;96:824-7.
9. Robles DT, Fain PR, Gottleib PA, Eisenbarth GS. The genetics of autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 2002;31:353-68.
10. Lee MT, Won JG, Lee TI, Yang HJ, Lin HD, Tang KT. The relationship between morning serum cortisol and the short ACTH test in the evaluation of adrenal insufficiency. Zhonghua Yi Xue Za Zhi (Taipei) 2002;65:580-7.
11. Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insufficiency [Published correction appears in Ann Intern Med 2004;140:315]. Ann Intern Med 2003;139:194-204.
12. Giordano R, Pellegrino M, Oleandri S, Baldi M, Balbo M, Laureti S, et al. Adrenal sensitivity to adrenocorticotropin 1-24 is reduced in patients with autoimmune polyglandular syndrome. J Clin Endocrinol Metab 2004;89:675-80.
13. Zarkovic M, Ciric J, Stojanovic M, Penezic Z, Trbojevic B, Drezgic M, et al. Optimizing the diagnostic criteria for standard (250-microg) and low dose (1-microg) adrenocorticotropin tests in the assessment of adrenal function. J Clin Endocrinol Metab 1999;84:3170-3.
14. Roberts CG, Ladenson PW. Hypothyroidism. Lancet 2004;363:793-803.
15. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27(suppl 1):S15-35.
16. Falorni A, Laureti S, De Bellis A, Zanchetta R, Tiberti C, Arnaldi G, et al., for the SIE Addison Study Group. Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. J Clin Endocrinol Metab 2004;89:1598-604.
17. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004;350:2068-79.
18. Gumieniak O, Farwell AP. Schmidt's syndrome and severe hyponatremia: report of an unusual case and review of the related literature. Endocr Pract 2003;9:384-8.